Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-DOTA-TOC PET/CT in Inflammatory Heart Disease
NCT04206163Completed
- Sponsor
- Region Västra Götaland
- Start
- Jan 2020
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Region Västra Götaland. Primary endpoints: Sensitivity of 68Ga-DOTA-TOC PET/CT versus contrast-enhanced MRI in patients with clinically suspected acute myocarditis at 2 years, Specificity of 68Ga-DOTA-TOC PET/CT versus contrast-enhanced MRI in patients with clinically suspected acute myocarditis at 2 years and 2 more. Started Jan 2020; status: completed.
Beyond the preview
Go deeper on NCT04206163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04206163.